83_FR_54815 83 FR 54605 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meetings

83 FR 54605 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 210 (October 30, 2018)

Page Range54605-54605
FR Document2018-23615

Federal Register, Volume 83 Issue 210 (Tuesday, October 30, 2018)
[Federal Register Volume 83, Number 210 (Tuesday, October 30, 2018)]
[Notices]
[Page 54605]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-23615]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel; NICHD K99 Teleconference Review.
    Date: November 29, 2018.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6710B Rockledge Drive, 
Bethesda, MD 20894 (Telephone Conference Call).
    Contact Person: Helen Huang, Scientific Review Branch (SRB), 
DER, Eunice Kennedy Shriver National Institute of Child Health and 
Human Development, NIH, DHHS, 6710B Rockledge Drive, Rm. 2125B, 
Bethesda, MD 20817, 301-435-8380, helen.huang@nih.gov.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel; Pediatric Critical Care and 
Trauma Scientist Development Program (K12) Teleconference Review.
    Date: December 3, 2018.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6710B Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Helen Huang, Scientific Review Branch (SRB), 
DER, Eunice Kennedy Shriver National Institute of Child Health and 
Human Development, NIH, DHHS, 6710B Rockledge Drive, Rm. 2125B, 
Bethesda, MD 20817, 301-435-8380, helen.huang@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: October 24, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-23615 Filed 10-29-18; 8:45 am]
 BILLING CODE 4140-01-P



                                                                            Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices                                               54605

                                               development and evaluation under a                      property such as patentable material,                 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                               research collaboration.                                 and personal information concerning                   as amended. The contract proposals and
                                                                                                       individuals associated with the grant                 the discussions could disclose
                                               Potential Commercial Applications
                                                                                                       applications, the disclosure of which                 confidential trade secrets or commercial
                                                  • Novel therapeutics for                             would constitute a clearly unwarranted                property such as patentable material,
                                               neurodegenerative diseases AND other                    invasion of personal privacy.                         and personal information concerning
                                               indications which involve c-Abl kinase                                                                        individuals associated with the contract
                                                                                                         Name of Committee: National Institute of
                                               (e.g., lysosomal storage disorders,                     Child Health and Human Development                    proposals, the disclosure of which
                                               cancers, etc.).                                         Special Emphasis Panel; NICHD K99                     would constitute a clearly unwarranted
                                               Competitive Advantages                                  Teleconference Review.                                invasion of personal privacy.
                                                                                                         Date: November 29, 2018.
                                                  • Novel compounds that have a                          Time: 2:00 p.m. to 4:00 p.m.
                                                                                                                                                               Name of Committee: National Institute on
                                               commercial advantage over those                                                                               Aging Special Emphasis Panel; Second Stage
                                                                                                         Agenda: To review and evaluate grant
                                                                                                                                                             Review.
                                               currently known because they are able                   applications.
                                                                                                                                                               Date: November 19, 2018.
                                               to selectively bind to c-Abl at an                        Place: National Institutes of Health, 6710B
                                                                                                                                                               Time: 8:30 a.m. to 4:00 p.m.
                                               allosteric site, can cross the blood-brain              Rockledge Drive, Bethesda, MD 20894
                                                                                                                                                               Agenda: To review and evaluate contract
                                                                                                       (Telephone Conference Call).
                                               barrier, and show robust efficacy in                      Contact Person: Helen Huang, Scientific
                                                                                                                                                             proposals.
                                               several neurodegenerative models. All                                                                           Place: National Institute on Aging,
                                                                                                       Review Branch (SRB), DER, Eunice Kennedy
                                               of this allows them to potentially treat                                                                      Gateway Building, Suite 2W200, 7201
                                                                                                       Shriver National Institute of Child Health
                                               neurodegenerative diseases, cancer etc.                                                                       Wisconsin Avenue, Bethesda, MD 20892.
                                                                                                       and Human Development, NIH, DHHS,
                                                                                                                                                               Contact Person: Kimberly Firth, Ph.D.,
                                                                                                       6710B Rockledge Drive, Rm. 2125B,
                                               Development Stage                                       Bethesda, MD 20817, 301–435–8380,
                                                                                                                                                             National Institutes of Health, National
                                                                                                                                                             Institute on Aging, Gateway Building, 7201
                                                 • Pre-Clinical (in vivo validation).                  helen.huang@nih.gov.
                                                                                                                                                             Wisconsin Avenue, Suite 2C212, Bethesda,
                                                                                                         Name of Committee: National Institute of            MD 20892, 301–402–7702, firthkm@
                                               Inventors                                               Child Health and Human Development                    mail.nih.gov.
                                                 • Juan Marugan, Marc Ferrer, Noel                     Special Emphasis Panel; Pediatric Critical
                                                                                                                                                             (Catalogue of Federal Domestic Assistance
                                               Southall, Andres Dulcey, Xin Hu,                        Care and Trauma Scientist Development
                                                                                                                                                             Program Nos. 93.866, Aging Research,
                                               Christopher Dextras, Daniel Talley,                     Program (K12) Teleconference Review.
                                                                                                                                                             National Institutes of Health, HHS)
                                               Alejandra Alvarez, Silvana Zanlungo.                      Date: December 3, 2018.
                                                                                                         Time: 2:00 p.m. to 4:00 p.m.                          Dated: October 24, 2018.
                                                 Intellectual Property: 1. C-ABL
                                                                                                         Agenda: To review and evaluate grant                Melanie J. Pantoja,
                                               TYROSINE KINASE INHIBITORY                              applications.
                                               COMPOUND EMBODIMENTS AND                                                                                      Program Analyst, Office of Federal Advisory
                                                                                                         Place: National Institutes of Health, 6710B         Committee Policy.
                                               METHODS OF MAKING AND USING                             Rockledge Drive, Bethesda, MD 20892
                                               THE SAME’’ U.S. Provisional Patent                                                                            [FR Doc. 2018–23614 Filed 10–29–18; 8:45 am]
                                                                                                       (Telephone Conference Call).
                                               Application NO. 62/641,126 filed on                       Contact Person: Helen Huang, Scientific             BILLING CODE 4140–01–P

                                               March 9, 2018 (HHS Ref. No. E–252–                      Review Branch (SRB), DER, Eunice Kennedy
                                               2017).                                                  Shriver National Institute of Child Health
                                                 Licensing Contact: Ami Gadhia, JD,                    and Human Development, NIH, DHHS,                     DEPARTMENT OF HEALTH AND
                                               LL.M., CLP, 301–217–6098;                               6710B Rockledge Drive, Rm. 2125B,                     HUMAN SERVICES
                                                                                                       Bethesda, MD 20817, 301–435–8380,
                                               ami.gadhia@nih.gov.                                     helen.huang@nih.gov.                                  National Institutes of Health
                                                 Dated: September 25, 2018.                            (Catalogue of Federal Domestic Assistance
                                               Lillianne M. Portilla Weingarten,                       Program Nos. 93.864, Population Research;             National Institute of Arthritis and
                                               Technology Development Coordinator,                     93.865, Research for Mothers and Children;            Musculoskeletal and Skin Diseases;
                                               National Center for Advancing Translational             93.929, Center for Medical Rehabilitation             Notice of Closed Meetings
                                               Sciences.                                               Research; 93.209, Contraception and
                                                                                                       Infertility Loan Repayment Program, National            Pursuant to section 10(d) of the
                                               [FR Doc. 2018–23616 Filed 10–29–18; 8:45 am]
                                                                                                       Institutes of Health, HHS)                            Federal Advisory Committee Act, as
                                               BILLING CODE 4140–01–P
                                                                                                         Dated: October 24, 2018.                            amended, notice is hereby given of the
                                                                                                       Ronald J. Livingston, Jr.,
                                                                                                                                                             following meetings.
                                                                                                                                                               The meetings will be closed to the
                                               DEPARTMENT OF HEALTH AND                                Program Analyst, Office of Federal Advisory
                                                                                                                                                             public in accordance with the
                                               HUMAN SERVICES                                          Committee Policy.
                                                                                                                                                             provisions set forth in sections
                                                                                                       [FR Doc. 2018–23615 Filed 10–29–18; 8:45 am]
                                               National Institutes of Health                                                                                 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                       BILLING CODE 4140–01–P
                                                                                                                                                             as amended. The grant applications and
                                               Eunice Kennedy Shriver National                                                                               the discussions could disclose
                                               Institute of Child Health and Human                                                                           confidential trade secrets or commercial
                                                                                                       DEPARTMENT OF HEALTH AND
                                               Development; Notice of Closed                                                                                 property such as patentable material,
                                                                                                       HUMAN SERVICES
                                               Meetings                                                                                                      and personal information concerning
                                                                                                       National Institutes of Health                         individuals associated with the grant
                                                 Pursuant to section 10(d) of the                                                                            applications, the disclosure of which
                                               Federal Advisory Committee Act, as                                                                            would constitute a clearly unwarranted
                                                                                                       National Institute on Aging; Notice of
                                               amended, notice is hereby given of the                                                                        invasion of personal privacy.
                                                                                                       Closed Meeting
khammond on DSK30JT082PROD with NOTICES




                                               following meetings.
                                                 The meetings will be closed to the                      Pursuant to section 10(d) of the                      Name of Committee: National Institute of
                                               public in accordance with the                                                                                 Arthritis and Musculoskeletal and Skin
                                                                                                       Federal Advisory Committee Act, as
                                                                                                                                                             Diseases Special Emphasis Panel; Ancillary
                                               provisions set forth in sections                        amended, notice is hereby given of the                Studies Application Review.
                                               552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              following meeting.                                      Date: November 2, 2018.
                                               as amended. The grant applications and                    The meeting will be closed to the                     Time: 12:00 p.m. to 5:00 p.m.
                                               the discussions could disclose                          public in accordance with the                           Agenda: To review and evaluate grant
                                               confidential trade secrets or commercial                provisions set forth in sections                      applications.



                                          VerDate Sep<11>2014   21:27 Oct 29, 2018   Jkt 247001   PO 00000   Frm 00040   Fmt 4703   Sfmt 4703   E:\FR\FM\30OCN1.SGM   30OCN1



Document Created: 2018-10-30 00:43:32
Document Modified: 2018-10-30 00:43:32
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 29, 2018.
FR Citation83 FR 54605 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR